The Study of Chromobox Protein Homolog 4 in 3D Organoid Models of Colon Cancer as a Potential Predictive Marker
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157385 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Vincenza Ciaramella und 7 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS SYNLAB SDN, 80143 Naples, Italy. Hauptthemen laut MEDLINE: Organoids, Colonic Neoplasms, Biomarkers, Tumor, Polycomb-Group Proteins. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Italian Ministry of Health Project “Ricerca Corrente”.
Abstract (Originalsprache)
The Chromobox (CBX) family comprises key epigenetic regulators involved in transcriptional repression through chromatin modifications. Dysregulation of polycomb CBX proteins has been linked to epigenetic gene silencing and cancer progression. However, the specific roles and prognostic value of CBX family members in colorectal cancer (CC) remain unclear. In this study, we show that CBX genes are significantly dysregulated in CC tissues and cell models compared to normal colorectal tissue. Among them, CBX4 and CBX8 emerged as the most upregulated isoforms in tumors. Functional analyses revealed that CBX4 overexpression enhances CC cell proliferation, while its silencing reduces tumor growth. Similarly, pharmacological inhibition of CBX4 in patient-derived tumor organoids led to decreased proliferation, supporting its pro-tumorigenic role. Immunofluorescence analysis further revealed alterations in NF-κB signaling upon CBX4 inhibition, along with reduced mRNA levels of pathway components including NF-κB, TNF, IL-1, and c-Myc. These findings point to a potential interplay between CBX4 and inflammation-related pathways in CC. Overall, our study highlights the oncogenic role of CBX4 in colorectal cancer and supports its potential as a novel therapeutic target and early biomarker for disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS SYNLAB SDN, 80143 Naples, Italy.
- Unit of Hepato-Biliary and Pancreatic Surgery, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy.
- Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy.
- Department of Medical, Movement and Well-being Sciences, University of Naples Parthenope, 80133 Naples, Italy.
ORCID-Profile: Francesco Izzo, Andrea Belli, Antonio Avallone, Alfonso De Stefano, Anna Maria Grimaldi
Förderung
- Italian Ministry of Health
- Italian Ministry of Health Project “Ricerca Corrente”
Zitieren
APA
Ciaramella, V., Belli, V., Izzo, F., Belli, A., Avallone, A., De Stefano, A., Soricelli, A., & Grimaldi, A. M. (2025). The Study of Chromobox Protein Homolog 4 in 3D Organoid Models of Colon Cancer as a Potential Predictive Marker. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157385
Vancouver
Ciaramella V, Belli V, Izzo F, Belli A, Avallone A, De Stefano A, et al. The Study of Chromobox Protein Homolog 4 in 3D Organoid Models of Colon Cancer as a Potential Predictive Marker. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157385
BibTeX
@article{Ciaramella2025,
author = {Ciaramella, Vincenza and Belli, Valentina and Izzo, Francesco and Belli, Andrea and Avallone, Antonio and De Stefano, Alfonso and Soricelli, Andrea and Grimaldi, Anna Maria},
title = {The Study of Chromobox Protein Homolog 4 in 3D Organoid Models of Colon Cancer as a Potential Predictive Marker},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157385}
}
EUVIMED